ctrl K

ARS Pharmaceuticals Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

14.20

0.23 (1.65%)

At close: May 01, 2025, 3:59 PM

14.21

0.11%

After-hours: May 01, 2025, 05:26 PM EDT

ARS Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	89.15M	30K	1.32M	5.51M	17.84M	n/a	n/a
Cost of Revenue	n/a	73K	17.32M	20.27M	14.07M	1.55M	1.42M
Gross Profit	89.15M	-43K	-16M	-14.77M	3.77M	-1.55M	-1.42M
Operating Income	-3.08M	-67.52M	-35.52M	-19.45M	-469K	-24.07M	-18.32M
Interest Income	n/a	n/a	n/a	800K	400K	100K	43K
Pretax Income	8.29M	-54.37M	-34.68M	-20.24M	-1.06M	-23.97M	-17.58M
Net Income	8M	-54.37M	-33.99M	-20.24M	-1.06M	-23.97M	-17.58M
Selling & General & Admin	71.67M	47.28M	18.46M	4.69M	4.23M	1.02M	2.1M
Research & Development	19.58M	20.27M	18.38M	20.27M	14.07M	21.5M	14.8M
Other Expenses	977K	n/a	974K	-789K	-596K	n/a	n/a
Operating Expenses	92.23M	67.55M	36.83M	24.96M	18.3M	22.52M	16.9M
Interest Expense	n/a	n/a	n/a	106K	29K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	92.23M	67.55M	36.83M	24.96M	18.3M	24.07M	18.32M
Income Tax Expense	288K	n/a	-694K	-230.56K	-200.3K	n/a	n/a
Shares Outstanding (Basic)	96.94M	95.22M	39.96M	28.87M	34.7M	33.07M	33.07M
Shares Outstanding (Diluted)	102.39M	95.22M	39.96M	28.87M	34.7M	33.07M	33.07M
EPS (Basic)	0.08	-0.57	-0.85	-0.7	-0.03	-0.72	-0.53
EPS (Diluted)	0.08	-0.57	-0.85	-0.7	-0.03	-0.72	-0.53
EBITDA	-3.08M	-67.45M	-35.52M	-19.24M	-463K	-22.52M	-16.9M
EBIT	-3.08M	-67.52M	-35.52M	-19.45M	-469K	-23.97M	-17.58M
Depreciation & Amortization	n/a	73K	319K	213K	1.71M	1.55M	1.42M